Latest Insights on Adamis Pharmaceuticals Corp (NASDAQ:ADMP)

Repost This

Las Vegas, NV -- (SBWIRE) -- 02/13/2014 -- Adamis Pharmaceuticals Corp (NASDAQ:ADMP) is a biopharmaceutical company that is engaged in the development and commercialization of specialty pharmaceutical products in the therapeutic areas of immunology, oncology and infectious diseases and allergy and respiratory.

Adamis Pharmaceuticals Corp focuses on developing of small molecule compounds, which comprise APC-100, APC-200, and APC-300 for treating human prostate cancer, telomerase vaccine technologies and other vaccine technologies that provide protection against various viral infectious agents.

The products of Adamis Pharmaceuticals Corp that are under development also comprise TeloB-VAX which is a novel cell-based vaccine product for prostate cancer and Savvy(C31G) which is a contraceptive gel. The company’s allergy and respiratory product pipeline includes Epinephrine Injection USP 1 which is a pre-filled single dose syringe product the emergency treatment of extreme acute allergic reactions or anaphylactic shock, APC-1000 which is a steroid hydrofluoroalkane (HFA) metered dose inhaler product for asthma and chronic obstructive pulmonary disease, APC-2000 which is a generic HFA bronchodilator and APC-3000, an HFA pressurized metered dose nasal steroid for the treatment of seasonal and perennial allergic rhinitis.

To find out what OTCMAGIC projects for Adamis Pharmaceuticals Corp for both short term and long term please click here: ADMP

OTCMAGIC Spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit OTCMAGIC right now and see what it’s all about for yourself! At 30,000 Visitors a Month and growing rapidly OTCMAGIC is the hottest thing in OTC Picks!

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: OTCMagic.com employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://OTCMagic.com/disclaimer. Release of Liability: Through use of this website viewing or using you agree to hold OTCMagic.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. OTCMagic.com affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCMagic.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCMagic.com. We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical. OTCMagic.com, nor any of its affiliates are not registered investment advisors or broker dealers